Ron-Bigger Shulamit
SEC insider (Form 3/4/5 filer). CIK 0002049407. Chief Operating Officer at Aktis Oncology, Inc. (AKTS). 4 reported Form 4/5 transactions since Sep 2024; latest on Jul 8, 2026. Located in BOSTON, MA.
Companies Ron-Bigger Shulamit has filed insider reports for
- Aktis Oncology, Inc. (AKTS): Officer, Chief Operating Officer
Ron-Bigger Shulamit
CIK: 0002049407
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (75.0%)
Position reduction
Option Exercises (M)1 (25.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AKTS
Aktis Oncology, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 8, 2026AKTS
Aktis Oncology, Inc.
ExerciseDirect50K shares at avg. $3.66$183K - Jul 8, 2026AKTS
Aktis Oncology, Inc.
SaleDirect15.8K shares at avg. $27.13$429K - Jul 8, 2026AKTS
Aktis Oncology, Inc.
SaleDirect30K shares at avg. $27.94$838K - Jul 8, 2026AKTS
Aktis Oncology, Inc.
SaleDirect4.2K shares at avg. $28.75$121K
1-4 of 4 transactions